Positive CHMP Recommendation for Approval of the subcutaneous Formulation of Vedolizumab for Maintenance Therapy in adult Patients with moderately to severely active Forms of ulcerative Colitis and Crohn's Disease-MedSci.cn

Positive CHMP Recommendation for Approval of the subcutaneous Formulation of Vedolizumab for Maintenance Therapy in adult Patients with moderately to severely active Forms of ulcerative Colitis and Crohn's Disease

[Anonymous]

VISCERAL MEDICINE, 2020; 36 (2): 153

科室
- - 订阅+
  - 更多科室
工具
服务